MSRRX
Price
$60.85
Change
+$0.61 (+1.01%)
Updated
Oct 20 closing price
Net Assets
8.09B
VSTSX
Price
$317.21
Change
+$3.54 (+1.13%)
Updated
Oct 20 closing price
Net Assets
2.02T
Interact to see
Advertisement

MSRRX vs VSTSX

Header iconMSRRX vs VSTSX Comparison
Open Charts MSRRX vs VSTSXBanner chart's image
MFS Research R2
Price$60.85
Change+$0.61 (+1.01%)
VolumeN/A
Net Assets8.09B
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.21
Change+$3.54 (+1.13%)
VolumeN/A
Net Assets2.02T
MSRRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MSRRX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSRRX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. MSRRX (8.09B). VSTSX pays higher dividends than MSRRX: VSTSX (1.15) vs MSRRX (0.20). MSRRX was incepted earlier than VSTSX: MSRRX (22 years) vs VSTSX (9 years). MSRRX (1.02) is less costly to investors than VSTSX (0.01). MSRRX is a more actively managed with annual turnover of: 20.00 vs. VSTSX (2.00). MSRRX has a lower initial minimum investment than VSTSX: MSRRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 14.67 vs. MSRRX (0.85). VSTSX return over 5 years is better than : 89.91 vs. MSRRX (28.86).
MSRRXVSTSXMSRRX / VSTSX
Total Expense Ratio1.020.0110,200%
Annual Report Gross Expense Ratio1.020.0110,200%
Fund Existence22 years9 years-
Gain YTD10.79814.30575%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.09B2.02T0%
Annual Yield % from dividends0.201.1517%
Returns for 1 year0.8514.676%
Returns for 3 years31.9777.0941%
Returns for 5 years28.8689.9132%
Returns for 10 years68.19N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT11.271.43
+14.53%
4D Molecular Therapeutics
INDP3.900.20
+5.41%
Indaptus Therapeutics Inc
APPN29.211.06
+3.77%
Appian Corp
LGO1.330.04
+3.10%
Largo
IONS73.550.46
+0.63%
Ionis Pharmaceuticals